Literature DB >> 12379189

Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders.

K Kaneyama1, N Segami, M Nishimura, T Suzuki, J Sato.   

Abstract

The concentrations of cytokines were measured by an ELISA in the synovial fluid from 117 patients with temporomandibular disorders (TMD) and correlated with degenerative changes of the condyle and clinical symptoms.Fifty-seven patients had degenerative changes of the condyle. The fluid from seven healthy volunteers was used as controls. The concentrations of interleukin-1beta (IL-1beta), tumour necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and interleukin-8 (IL-8) were significantly higher in the synovial fluid of patients than controls (P<0.05). The concentration of IL-6 was significantly higher in the patients with degenerative changes than in other patients (P<0.05). The detection of IL-8 correlated with the concentrations of IL-6 and TNF-alpha. However, there was no correlation between the concentrations of any cytokines and symptoms. In conclusion, the cytokines in the synovial fluid may participate in the pathogenesis of TMD. In particular, IL-6 is important and may be associated with the development of osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379189

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  26 in total

1.  Chronic inflammation and pain in a tumor necrosis factor receptor (TNFR) (p55/p75-/-) dual deficient murine model.

Authors:  Karin N Westlund; Liping Zhang; Fei Ma; Helieh S Oz
Journal:  Transl Res       Date:  2011-11-08       Impact factor: 7.012

Review 2.  [Cytokine regulation and pain. Results of experimental and clinical research].

Authors:  N Uçeyler; C Sommer
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

3.  The IL-1Ra gene variable number tandem repeat variant is associated with susceptibility to temporomandibular disorders in Turkish population.

Authors:  Mehmet Kemal Tumer; Ayse Feyda Nursal; Akin Tekcan; Kaan Yerliyurt; Anastasia Geyko; Serbulent Yigit
Journal:  J Clin Lab Anal       Date:  2017-06-14       Impact factor: 2.352

4.  Differences in signal intensities of temporomandibular joint (TMJ) effusion on fluid-attenuated inversion recovery (FLAIR) images.

Authors:  Mika Otonari-Yamamoto; Kenichi Imoto
Journal:  Oral Radiol       Date:  2018-01-20       Impact factor: 1.852

5.  Inflammatory 'double hit' model of temporomandibular joint disorder with elevated CCL2, CXCL9, CXCL10, RANTES and behavioural hypersensitivity in TNFR1/R2-/- mice.

Authors:  S L McIlwrath; R Nesemeier; F Ma; H S Oz; L Zhang; K N Westlund
Journal:  Eur J Pain       Date:  2017-03-20       Impact factor: 3.931

6.  TEMPOROMANDIBULAR PAIN DYSFUNCTION SYNDROME IN PATIENTS ATTENDING LAGOS UNIVERSITY TEACHING HOSPITAL, LAGOS, NIGERIA.

Authors:  O M Eweka; O M Ogundana; G A Agbelusi
Journal:  J West Afr Coll Surg       Date:  2016 Jan-Mar

Review 7.  Pathogenesis of degenerative temporomandibular joint arthritides.

Authors:  Stephen B Milam
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

8.  The potential of multiple synovial-fluid protein-concentration analyses in the assessment of knee osteoarthritis.

Authors:  Jeffrey B Driban; Easwaran Balasubramanian; Mamta Amin; Michael R Sitler; Marvin C Ziskin; Mary F Barbe
Journal:  J Sport Rehabil       Date:  2010-11       Impact factor: 1.931

9.  Mutual effect between neuropeptides and inflammatory cytokines in neurogenic SMSCs of human temporomandibular joint.

Authors:  Zhi-Ming Liu; You-Jian Peng; Xing Long; Jian Li; Jin Ke; Wei Fang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

10.  Effect of a functional variant of tumor necrosis factor-β gene in temporomandibular disorders: A pilot study.

Authors:  Kaan Yerliyurt; Ayse Feyda Nursal; Akin Tekcan; Nevin Karakus; Mehmet K Tumer; Serbulent Yigit
Journal:  J Clin Lab Anal       Date:  2018-08-20       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.